Events¶

Overview

Scope Summit¶

(13-14 October 2026 - Barcelona, Spain)

Yes, You Can (Digitalise That) - Streamlining Study Design through Protocol Digitalisation

(by Camilla Kehler, Associate Digital Product Director, Novo)

Too often, clinical trial protocols are held together by a patchwork of disconnected platforms and manual workarounds, a system built on repeated data entry, mismatched formats, and limited data consistency. It’s inefficient, error-prone, and a major barrier to accelerating study start-up. This session will explore how biopharmaceutical companies are changing that by digitalizing protocol design and authoring. Using an open-source, vendor-agnostic data model, organizations are automating data flow, improving interoperability across systems, and gaining insight to inform better study design. Join us to see how this approach can unlock new use cases from registry submission to statistical analysis; automate data flow and interoperability between systems; reduce study start-up effort, cycle time, and complexity; improve quality and compliance

Additional event information here.

Community Meeting (virtual)¶

(13 October 2026, virtual event, 15:00-16:00 CEST)

Join us at the OpenStudyBuilder community meeting! Don't miss out on the opportunity to ask any questions to us! We can demonstrate various functionality and provide insightful answers. We can discuss on a wide range of subjects.

You can register for the event here.

PHUSE EU Connect¶

(15-18 November 2026 - Glasgow, Scotland)

We will join the PHUSE EU Connect in Glasgow. Please come by, talk to us and also checkout our presentation on collaboration challenges.

Additional event information and registration is available here.

Beyond Code: Collaboration Challenges in Pharma Open Source

(by Mikkel Traun, Novo Nordisk and Katja Glaß, Consultant)

Open-source adoption in the pharmaceutical industry continues to grow, yet sustainable contributions and long-term collaboration remain significant challenges. Compared to other industries, contribution models in pharma are often limited by complexity, compliance expectations, fragmented ownership, and uncertainty around governance and maintenance responsibilities.

This presentation explores key challenges surrounding open-source collaboration in clinical research using OpenStudyBuilder as a practical example. It outlines the considerations, experiences, and developments that led to the creation of a collaborative alliance model designed to strengthen industry alignment, co-development, and long-term sustainability. The session highlights how the alliance evolved, its current state, and its future direction in advancing OpenStudyBuilder toward enabling a truly connected digital data flow for the pharmaceutical industry.

OpenStudyBuilder Demonstration¶

New to OpenStudyBuilder or curious about what it can do today? In Q4 2026, we will host a webinar introducing the solution with a live demonstration: from setting up a study and building its Schedule of Activities, through reusing study metadata downstream, to managing standards in the Library. There will be plenty of time for your questions.

OpenStudyBuilder Collaboration¶

Interested in shaping OpenStudyBuilder together with us? In a second webinar in Q4 2026, we will introduce the collaboration model: how organizations can get involved, how the partners work together today, and what the partners gain from joining. Again, we will leave ample room for questions and discussion.